- February 1, 2021
- Natlaw Review
FDA’s NCTR Highlights Its Nanotechnology-Related Activities in 2020
The January 29, 2021, issue of the U.S. Food and Drug Administration’s (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research’s (NCTR) nanotechnology-related activities in 2020.
CONTINUE READING ON www.natlawreview.com